Oyster Point Pharma, Inc. Common Stock
OYST
OYST was delisted on the 30th of December, 2022.
72 hedge funds and large institutions have $520M invested in Oyster Point Pharma, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 24 increasing their positions, 8 reducing their positions, and 2 closing their positions.
1,450% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 2
200% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 8
67% more funds holding
Funds holding: 43 → 72 (+29)
12% more capital invested
Capital invested by funds: $465M → $520M (+$54.8M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$40.3M |
| 2 |
RI
RTW Investments
New York
|
+$28.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.6M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$7.89M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$1.39M |
| 2 |
MA
MCF Advisors
Covington,
Kentucky
|
-$358K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$283K |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
-$138K |
| 5 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$99.6K |
OYST Hedge Fund Activity: Q2 2020 in Review
72 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Oyster Point Pharma, Inc. Common Stock (OYST) for Q2 2020, worth a combined $520M — up 12% from $465M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new OYST positions and 2 closed out — a net gain of 29 holders — while 24 added to existing stakes and 8 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $40.3M. The largest seller was Board of Trustees of The Leland Stanford Junior University, cutting an estimated $1.39M.
- 72 institutional investors held Oyster Point Pharma, Inc. Common Stock (OYST) as of Q2 2020, up from 43 in Q1 2020.
- Funds reported $520M of Oyster Point Pharma, Inc. Common Stock stock for Q2 2020, up 12% quarter-over-quarter.
- 31 funds opened new Oyster Point Pharma, Inc. Common Stock positions in Q2 2020 and 2 closed out, a net change of +29 holders.
- The largest Oyster Point Pharma, Inc. Common Stock buyer in Q2 2020 was Wellington Management Group, an estimated $40.3M added.
- The largest Oyster Point Pharma, Inc. Common Stock seller in Q2 2020 was Board of Trustees of The Leland Stanford Junior University, an estimated $1.39M sold.
Based on aggregated 13F filings for Q2 2020.